SBHMY
Price
$9.48
Change
+$0.69 (+7.85%)
Updated
Apr 21 closing price
Capitalization
11.78B
SYBX
Price
$1.22
Change
+$0.02 (+1.67%)
Updated
Jun 26 closing price
Capitalization
14.27M
Interact to see
Advertisement

SBHMY vs SYBX

Header iconSBHMY vs SYBX Comparison
Open Charts SBHMY vs SYBXBanner chart's image
Sino Biopharmaceutical
Price$9.48
Change+$0.69 (+7.85%)
Volume$185
Capitalization11.78B
Synlogic
Price$1.22
Change+$0.02 (+1.67%)
Volume$3.11K
Capitalization14.27M
SBHMY vs SYBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SBHMY vs. SYBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Hold and SYBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (SBHMY: $9.38 vs. SYBX: $1.22)
Brand notoriety: SBHMY and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 100% vs. SYBX: 30%
Market capitalization -- SBHMY: $11.78B vs. SYBX: $14.27M
SBHMY [@Biotechnology] is valued at $11.78B. SYBX’s [@Biotechnology] market capitalization is $14.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 3 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • SBHMY’s FA Score: 3 green, 2 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, SBHMY is a better buy in the long-term than SYBX.

Price Growth

SBHMY (@Biotechnology) experienced а 0.00% price change this week, while SYBX (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

SBHMY is expected to report earnings on Apr 29, 2025.

SYBX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
SBHMY($11.8B) has a higher market cap than SYBX($14.3M). SBHMY has higher P/E ratio than SYBX: SBHMY (32.41) vs SYBX (5.55). SBHMY YTD gains are higher at: 13.737 vs. SYBX (-12.857). SBHMY has higher annual earnings (EBITDA): 6.89B vs. SYBX (-13.66M). SBHMY has higher revenues than SYBX: SBHMY (28.9B) vs SYBX (0).
SBHMYSYBXSBHMY / SYBX
Capitalization11.8B14.3M82,517%
EBITDA6.89B-13.66M-50,483%
Gain YTD13.737-12.857-107%
P/E Ratio32.415.55584%
Revenue28.9B0-
Total CashN/A17.3M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
SBHMY vs SYBX: Fundamental Ratings
SBHMY
SYBX
OUTLOOK RATING
1..100
444
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1946
PRICE GROWTH RATING
1..100
4760
P/E GROWTH RATING
1..100
1838
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (2) in the null industry is significantly better than the same rating for SYBX (86) in the Biotechnology industry. This means that SBHMY’s stock grew significantly faster than SYBX’s over the last 12 months.

SBHMY's Profit vs Risk Rating (100) in the null industry is in the same range as SYBX (100) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's SMR Rating (19) in the null industry is in the same range as SYBX (46) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's Price Growth Rating (47) in the null industry is in the same range as SYBX (60) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's P/E Growth Rating (18) in the null industry is in the same range as SYBX (38) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGVEX26.040.22
+0.85%
American Funds Global Insight F-1
AIERX22.69N/A
N/A
Invesco EQV International Equity R
SPXKX76.35N/A
N/A
Shelton S&P 500 Index K
DHMAX25.31N/A
N/A
Diamond Hill Small-Mid Cap Inv
BUIOX15.62N/A
N/A
Buffalo Early Stage Growth Instl

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
-1.81%
SYBX - SBHMY
34%
Loosely correlated
+1.67%
BTAI - SBHMY
32%
Poorly correlated
-0.98%
CLRPF - SBHMY
24%
Poorly correlated
+5.07%
VIVS - SBHMY
20%
Poorly correlated
-7.94%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with NEUP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+1.67%
NEUP - SYBX
64%
Loosely correlated
-2.86%
BTAI - SYBX
37%
Loosely correlated
-0.98%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
+7.88%
ATXS - SYBX
29%
Poorly correlated
-3.72%
More